Distinguished in Atrial Septal Defect (ASD)

Francois Godart

Lille, FR 
Distinguished in Atrial Septal Defect (ASD)
Lille, FR 
OverviewLocationsClinical Research

Overview

Francois Godart practices in Lille, France. Mr. Godart is rated as a Distinguished expert by MediFind in the treatment of Atrial Septal Defect (ASD). His top areas of expertise are Atrial Septal Defect (ASD), Patent Foramen Ovale, Ventricular Septal Defects, Congenital Heart Disease (CHD), and Patent Foramen Ovale Repair.

His clinical research consists of co-authoring 60 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 12 articles in the study of Atrial Septal Defect (ASD).

Gender
Male

Locations

Lille, 59000, France
Other Locations
Nantes, France
Libourne, France
INSERM 894, INSERM 1148, University Paris Est Creteil, INSERM 894, INSERM 1191, Dijon Stroke Registry, EA 7460, INSERM 1059, INSERM 1078, Lens, France
Bordeaux, 33000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Non Interventional Study on Pulmonary Valve Replacement by Thranscatheter Pulmonary Valve Melody™
Non Interventional Study on Pulmonary Valve Replacement by Thranscatheter Pulmonary Valve Melody™
Enrollment Status: Completed
Publish Date: July 03, 2025
Intervention Type: Device
Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease
Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease
Enrollment Status: Completed
Publish Date: August 22, 2017
Intervention Type: Other
Study Phase: Not Applicable
View 1 Less Clinical Trial

60 Total Publications

Safety and efficacy of transcatheter correction of sinus venosus defect using 70-100mm-long partially covered Optimus-CVS® XXL stents compared with surgery: The OPTIVENOSUS study design.
Safety and efficacy of transcatheter correction of sinus venosus defect using 70-100mm-long partially covered Optimus-CVS® XXL stents compared with surgery: The OPTIVENOSUS study design.
Journal: Archives of cardiovascular diseases
Published: March 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Godart's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile